Intensive ketamine use for multiple years: A case report.
James X. Liu, Erin Zerbo, Stephen Ross
Am J Addict January 1, 2015 DOI: 10.1111/ajad.12153 via PubMed
Summary
AI-generated from the abstractA patient with bipolar I disorder and a long history of substance dependence used large daily doses of ketamine (1-3 g) for five years. He reported acute antidepressant effects and reduced cravings for alcohol. Although his use was unsustainable and led to inpatient admission, he experienced no withdrawal syndrome and showed no observable cognitive deficits after stopping. This unique profile suggests that further research into ketamine's risks and therapeutic potential for mood and addiction disorders is warranted.
Study at a glance
| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A patient with bipolar I disorder and extensive substance dependence |
| Intervention | Ketamine |
| Dose | 1-3 g daily |
| Duration | 5 years of daily use |
| Keywords | Ketamine recovery Ketamine rehabilitation Ketamine healing Ketamine remission Ketamine treatment success |
| Citations | 17 |
| Key finding | A patient who used large daily doses of ketamine for five years reported acute antidepressant effects and reduced alcohol cravings, and experienced no withdrawal or cognitive deficits upon cessation. |
Abstract
Ketamine is known within the medical field for its anesthetic properties, yet its unique psychedelic and antidepressant properties are being increasingly recognized. We document the case of a patient with bipolar I disorder and an extensive history of substance dependence who used large doses of ketamine (1-3 g) on a daily basis over a period of 5 years, and described acute antidepressant effects as well as diminished cravings for alcohol. While his use was untenable and ultimately led to an inpatient admission, it is notable that he did not experience a withdrawal syndrome nor did he have any observable cognitive deficits upon cessation of use. Such a unique drug profile suggests that further exploration of its risks and therapeutic potential in treating mood and addiction disorders is warranted.